Advertisement

Topics

Why Former Novartis CEO Joe Jimenez Joined A Microbiome Startup’s Board

07:00 EDT 21 Sep 2018 | Forbes

uBiome, a San Francisco startup that sells commercial tests that use DNA sequencing to identify what microbes are in a person's stool or, for one test, in the vagina, has raised $83 million from venture capitalists to fund an entrée into drug development.

Original Article: Why Former Novartis CEO Joe Jimenez Joined A Microbiome Startup’s Board

NEXT ARTICLE

More From BioPortfolio on "Why Former Novartis CEO Joe Jimenez Joined A Microbiome Startup’s Board"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...